Pre-Exposure Prophylaxis

• 

  Subject Areas on Research

  • "Getting to Zero" Among Men Who Have Sex with Men in China: a Review of the HIV Care Continuum. 
  • "We're Not Done". 
  • A Medical Care Missed Opportunity: Preexposure Prophylaxis and Young Black Men Who Have Sex With Men. 
  • A Qualitative Exploration of Various Stigmas Impacting HIV Pre-Exposure Prophylaxis (PrEP) Uptake Among African American Young Adults. 
  • Acceptability of a Community Health Worker Program to Link High-Risk People in Jail to HIV Pre-Exposure Prophylaxis. 
  • Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city. 
  • Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials. 
  • Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States. 
  • An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S. 
  • An update on the management of PONV in a pediatric patient. 
  • Antiretroviral chemoprophylaxis: PROUD and pragmatism. 
  • Assessing the use of surveillance data to estimate the impact of prevention interventions on HIV incidence in cluster-randomized controlled trials. 
  • Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically Black universities (HBCU): a cross-sectional survey. 
  • Barriers to linking high-risk jail detainees to HIV pre-exposure prophylaxis. 
  • Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis. 
  • Combination HIV prevention among MSM in South Africa: results from agent-based modeling. 
  • Community-Informed Development of a Campaign to Increase HIV Pre-exposure Prophylaxis (PrEP) Awareness Among African-American Young Adults. 
  • Defining the HIV pre-exposure prophylaxis care continuum. 
  • Development of a Human Immunodeficiency Virus Risk Prediction Model Using Electronic Health Record Data From an Academic Health System in the Southern United States. 
  • Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women. 
  • Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials. 
  • Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon. 
  • Engagement of Gay Men and Other Men Who Have Sex with Men (MSM) in the Response to HIV: A Critical Step in Achieving an AIDS-Free Generation. 
  • Episodic Use of Pre-Exposure Prophylaxis Among Young Cisgender Women in Siaya County, Kenya. 
  • Examining Factors that Impact Intentions to Use Pre-Exposure Prophylaxis Among African-American Young Adults. 
  • Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States. 
  • Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry? 
  • Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy. 
  • Feasibility, Acceptability, and Preliminary Efficacy of a Gamified Mobile Health Contingency Management Intervention for PrEP Adherence Among Black MSM. 
  • Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic. 
  • Getting youth PrEPared: adolescent consent laws and implications for the availability of PrEP among youth in countries outside of the United States. 
  • HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers. 
  • HIV Prevention During the COVID-19 Pandemic: Sexual Activity and PrEP Use Among Black Same-Gender-Loving Men and Black Cisgender Women. 
  • HIV drug resistance in a cohort of HIV-infected MSM in the United States. 
  • HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami. 
  • INTRODUCTION Disrupting the Status Quo: Building Equitable Access to HIV PrEP in the US through Innovative Financing. 
  • Identification of Determinants and Implementation Strategies to Increase PrEP Uptake Among Black Same Gender-Loving Men in Mecklenburg County, North Carolina: The PrEP-MECK Study. 
  • Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge. 
  • Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model. 
  • Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy. 
  • Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modelling study for HPTN 078. 
  • Institutional distrust among gay, bisexual, and other men who have sex with men as a barrier to accessing pre-exposure prophylaxis (PrEP). 
  • Interest and Knowledge of HIV Pre-Exposure Prophylaxis in a Unified Jail and Prison Setting. 
  • Kidney injury biomarkers during exposure to tenofovir-based preexposure prophylaxis. 
  • Linking Women Experiencing Incarceration to Community-Based HIV Pre-Exposure Prophylaxis Care: A Qualitative Study. 
  • Linking women experiencing incarceration to community-based HIV pre-exposure prophylaxis care: protocol of a pilot trial. 
  • Longitudinal pre-exposure prophylaxis (PrEP) acceptability, initiation and adherence among criminal justice-involved adults in the USA: the Southern PrEP Cohort Study (SPECS) protocol. 
  • Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women. 
  • Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs. 
  • Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa. 
  • Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial. 
  • Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care. 
  • Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States. 
  • Perceived Interruptions to HIV Prevention and Treatment Services Associated With COVID-19 for Gay, Bisexual, and Other Men Who Have Sex With Men in 20 Countries. 
  • Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design. 
  • Perceptions on HIV Pre-Exposure Prophylaxis Among Urgent Care Clinicians in the Southern United States. 
  • Perspectives of Black women in the United States on salon-based intervention to promote the uptake of pre-exposure prophylaxis (PrEP) for HIV. 
  • Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug. 
  • PrEP Awareness, Use, Intention to Use, and Information Source Among Geosocial Networking Application Users in Mexico in 2018-2019. 
  • PrEP Disclosure Experiences of Gay and Bisexual Men in Guatemala. 
  • Pre-Exposure Prophylaxis for HIV Infection as a Public Health Tool. 
  • Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island. 
  • Pre-exposure prophylaxis awareness, use, and intention to use in a regional sample of Latin American geosocial networking application users in 2018-2019. 
  • Pre-exposure prophylaxis for people who inject drugs and their sex partners. 
  • Pre-exposure prophylaxis works--it's time to deliver. 
  • Predictors of Willingness to Diffuse PrEP Information within Ego-Centric Networks of Women Who Inject Drugs. 
  • Preexposure Prophylaxis Outcomes in an Urban Community in North Carolina: Discontinuation of Care and Sexually Transmitted Infections. 
  • Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP. 
  • Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study. 
  • Public Awareness of HIV Pre-Exposure Prophylaxis in Durham, North Carolina: Results of a Community Survey. 
  • Real-world safety of pre-exposure prophylaxis for HIV. 
  • Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis. 
  • Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study. 
  • Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination. 
  • Sex Tourism and Pre-Exposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men. 
  • Silver bullets and structural impediments to HIV prevention. 
  • Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. 
  • The Impact of Preexposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model. 
  • The Invisible US Hispanic/Latino HIV Crisis: Addressing Gaps in the National Response. 
  • The Path to Implementation of HIV Pre-exposure Prophylaxis for People Involved in Criminal Justice Systems. 
  • The global response and unmet actions for HIV and sex workers. 
  • The global response to HIV in men who have sex with men. 
  • The persistent and evolving HIV epidemic in American men who have sex with men. 
  • The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study. 
  • The science of Durban, AIDS 2016. 
  • US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review. 
  • Understanding Retention in Pre-Exposure Prophylaxis Care in the South: Insights from an Academic HIV Prevention Clinic. 
  • Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis. 
  • Using Participatory Methods to Assess PrEP Interest and Uptake Among Young People Living in the Southeastern US: A Mixed Methods Assessment. 
  • When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling. 
  • Youth at risk of HIV: the overlooked US HIV prevention crisis. 
• 

  Keywords of People

  • Guilamo-Ramos, Vincent, Dean of the School of Nursing, School of Nursing